MicroPort CardioFlow Medtech Corporation (HKG:2160)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.620
+0.160 (4.62%)
Mar 10, 2026, 4:08 PM HKT
-39.67%
Market Cap 4.41B
Revenue (ttm) 402.73M
Net Income (ttm) 5.32M
Shares Out 1.27B
EPS (ttm) 0.01
PE Ratio 828.64
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 701,900
Average Volume 715,062
Open 3.600
Previous Close 3.460
Day's Range 3.400 - 3.640
52-Week Range 0.810 - 8.450
Beta 0.29
RSI 36.17
Earnings Date Mar 27, 2026

About HKG:2160

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It’s product portfolio includes transcatheter aortic valves, left atrial appendage closure, tran... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2009
Employees 417
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2160
Full Company Profile

Financial Performance

In 2024, HKG:2160's revenue was 361.57 million, an increase of 7.54% compared to the previous year's 336.22 million. Losses were -49.45 million, -89.51% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.